Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021;19(4):583-596.
doi: 10.1007/s11938-021-00364-9. Epub 2021 Nov 22.

Health Maintenance for Adult Patients with Inflammatory Bowel Disease

Affiliations
Review

Health Maintenance for Adult Patients with Inflammatory Bowel Disease

Jana G Hashash et al. Curr Treat Options Gastroenterol. 2021.

Abstract

Purpose of review: This review serves as a summary of healthcare maintenance items that should be addressed when managing patients with inflammatory bowel disease (IBD). This manuscript discusses vaccine-preventable illnesses, cancer prevention recommendations, and other screenings that are important to gastroenterologists and primary care physicians caring for patients with IBD.

Recent findings: Patients with IBD often require immunomodulator agents and/or biologics to induce and maintain disease remission which can increase the risk of developing several infections. Also, subsets of patients with IBD are at an increased risk for a number of malignancies including colon, cervical, and skin cancers.

Summary: Staying up-to-date with health care maintenance of patients with IBD is critical, especially given their increased risk for vaccine-preventable infections as well as comorbidities such as cancers, bone health, and mood disorders. Gastroenterologists and primary care physicians should familiarize themselves with the required screenings and vaccines that are recommended for adult patients with IBD, particularly those who are immunosuppressed.

Keywords: Healthcare maintenance; Inflammatory bowel disease; Preventive care; Screening; Vaccinations.

PubMed Disclaimer

Conflict of interest statement

Conflict of InterestJana G. Hashash declares no competing interests. Michael F. Picco declares no competing interests. Dr. Farraye is a consultant for Arena, BMS, Braintree labs, GI Reviewers, GSK, Innovation Pharmaceuticals, Iterative scopes, Janssen, Pfizer and Sebela. He sits on a data safety monitoring board for Lilly and TheraVance.

References

References and Recommended Reading

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
    1. Bernstein CN, Blanchard JF, Rawsthorne P, Yu N. The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study. Am J Gastroenterol. 2001;96(4):1116–1122. doi: 10.1111/j.1572-0241.2001.03756.x. - DOI - PubMed
    1. Mir FA, Kane SV. Health maintenance in inflammatory bowel disease. Curr Gastroenterol Rep. 2018;20(5):1–6. doi: 10.1007/s11894-018-0621-1. - DOI - PubMed
    1. Selby L, Kane S, Wilson J, et al. Receipt of preventive health services by IBD patients is significantly lower than by primary care patients. Inflamm Bowel Dis. 2008;14(2):253–258. doi: 10.1002/ibd.20266. - DOI - PubMed
    1. Malhi G, Rumman A, Thanabalan R, et al. Vaccination in inflammatory bowel disease patients: attitudes, knowledge, and uptake. J Crohn's Colitis . 2015;9(6):439–444. doi: 10.1093/ecco-jcc/jjv064. - DOI - PubMed
    1. Wasan SK, Coukos JA, Farraye FA. Vaccinating the inflammatory bowel disease patient: deficiencies in gastroenterologists knowledge. Inflamm Bowel Dis. 2011;17(12):2536–2540. doi: 10.1002/ibd.21667. - DOI - PubMed